This Morning's Technical Outlook on Long-Term Care Facilities Stocks -- Brookdale Senior Living, Envision Healthcare, Genesis Healthcare, and Kindred Healthcare
NEW YORK, Nov. 29, 2017 /PRNewswire/ --
In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on BKD, EVHC, GEN, and KND which is a click away at www.wallstequities.com/registration. In today's pre-market research, WallStEquities.com covers the following equities: Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Corp. (NYSE: EVHC), Genesis Healthcare Inc. (NYSE: GEN), and Kindred Healthcare Inc. (NYSE: KND). Companies in the Nursing Homes and Long-Term Care Facilities industry provide long-term skilled nursing care, other types of care, and social services in residential facilities. With Wall St. Equities' free research reports get an edge over stock markets, sign up now at: www.wallstequities.com/registration.
Brookdale Senior Living
Brentwood, Tennessee headquartered Brookdale Senior Living Inc.'s shares closed Tuesday's trading session flat at $10.72. The stock recorded a trading volume of 1.42 million shares. The Company's shares have advanced 11.78% in the last month. The stock is trading 3.05% above its 50-day moving average. Additionally, shares of the Company, which owns and operates senior living communities in the US, have a Relative Strength Index (RSI) of 57.91.
On November 08th, 2017, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with a decrease of the target price from $16 a share to $13 a share.
On November 13th, 2017, Brookdale Senior Living announced that 17 of its skilled nursing communities made the cut for this year's "Best Nursing Homes" list by US News & World Report. Each facility is rated on a five-level scale, and the "best" designation is given to those that earn the top-rated label in care, safety, health inspections, staffing, and other criteria. Our free and thorough report on BKD awaits you at: www.wallstequities.com/registration/?symbol=BKD
Envision Healthcare
On Tuesday, shares in Nashville, Tennessee-based Envision Healthcare Corp. recorded a trading volume of 3.05 million shares. The stock rose 2.16%, ending the day at $30.72. The Company's shares are trading below their 50-day moving average by 18.84%. Furthermore, shares of Envision Healthcare, which through its subsidiaries, provides various healthcare services in the US, have an RSI of 42.84.
On November 17th, 2017, research firm Mizuho reiterated its 'Neutral' rating on the Company's stock with a decrease of the target price from $57 a share to $31 a share. EVHC complimentary research coverage a few simple steps away at: www.wallstequities.com/registration/?symbol=EVHC
Genesis Healthcare
Kennett Square, Pennsylvania headquartered Genesis Healthcare Inc.'s stock finished the day 12.17% lower at $0.75. A total volume of 873,470 shares was traded, which was above their three months average volume of 353,490 shares. The Company's shares are trading below their 50-day moving average by 25.09%. Additionally, shares of Genesis Healthcare, which together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the US, have an RSI of 24.05.
On November 08th, 2017, Genesis Healthcare announced its results for Q3 ended September 30th, 2017. US GAAP revenue in Q3 2017 was $1.32 billion, and US GAAP net loss attributable to the Company was $373.8 million. Adjusted EBITDAR in the quarter was $147.8 million and adjusted EBITDA was $109.1 million. Register for your free research report on GEN at: www.wallstequities.com/registration/?symbol=GEN
Kindred Healthcare
Shares in Louisville, Kentucky headquartered Kindred Healthcare Inc. ended yesterday's session 3.77% lower at $7.65. The stock recorded a trading volume of 829,275 shares. The Company's shares have advanced 26.45% in the last one month and 2.00% over the previous three months. The stock is trading 13.48% above its 50-day moving average. Moreover, shares of Kindred Healthcare, which provides healthcare services in the US, have an RSI of 54.51.
On November 07th, 2017, Kindred Healthcare announced its results for Q3 ended September 30th, 2017. Consolidated revenues were $1.48 billion for the quarter, GAAP loss from continuing operations was $18.4 million, core EBITDAR declined to $156.9 million, and core EBITDA declined to $83.9 million. GAAP operating cash flows for Q3 2017 were $8.5 million, core operating cash flows were $29.8 million, and core free cash flows were $3.3 million.
On November 20th, 2017, research firm Stifel upgraded the Company's stock rating from 'Sell' to 'Hold' with a target price of $7 per share. Wall St. Equities' downloadable research report on KND available at: www.wallstequities.com/registration/?symbol=KND
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities
Share this article